SEC Form 4 · accession 0001179110-15-004512
Ocata Therapeutics, Inc. · OCAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul K Wotton
Officer — President and CEO · Director
Period of report
Mar 5, 2015
Accepted (ET)
Mar 9, 2015 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001140098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 5, 2015 | A | 10,000 | — | A | 310,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represent Stock Unit Awards to vest at a rate one-third on the first anniversary of the date of grant; an additional one-third on the second anniversary of the date of grant; and the remaining one-third on the third anniversary of the date of grant, all in accordance with and subject to the terms and conditions of the Corporation's 2014 Stock Option and Incentive Plan (the "Plan").